Influence of androgen deprivation therapy on volume of anatomic zones of prostate in patients with prostate cancer using magnetic resonance imaging

Urology

Volumn 63, Issue 5, 2004, Pages 917-921

  Nishiyama, Tsutomu ^a   Tomita, Yoshihiko ^a   Takahashi, Kota ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER INHIBITION; CANCER LOCALIZATION; CANCER REGRESSION; CANCER SIZE; CASTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME;

AGED; ANDROGEN ANTAGONISTS; FLUTAMIDE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORCHIECTOMY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 2342507716     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.11.030     Document Type: Article

References (22)

1. Peters C.A., Walsh P.C. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med. 317:1987;599-604
2. McConnell J.D. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia. Urol Clin North Am. 17:1990;661-670
3. Gormley G.J., Stoner E., Bruskewitz R.C., et al. Finasteride Study Group. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 327:1992;1185-1191
4. Resnick M.I., Willard J.W., Boyce W.H. Transrectal ultrasonography in the evaluation of patients with prostatic carcinoma. J Urol. 124:1980;482-484
5. Hastak S.M., Gammelgaard J., Holm H.H. Transrectal ultrasonic volume determination of the prostate - a preoperative and postoperative study. J Urol. 127:1982;1115-1118
6. Hedvig H., Dooms G.C., McNeal J.E., et al. MR imaging of the prostate gland normal anatomy. AJR Am J Roentogenol. 148:1987;51-58
7. Williams A.M., Simon I., Landis P.K., et al. Prostatic growth rate determined from MRI data age-related longitudinal changes. J Androl. 20:1999;474-480
8. Tempany C.M.C., Partin A.W., Zerhouni E.A., et al. The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in man with benign prostatic hyperplasia. Prostate. 22:1993;39-42
9. Schiebler M.L., Tomaszewski J.E., Bezzi M., et al. Prostatic carcinoma and benign prostatic hyperplasia correlation of high-resolution MR and histopathologic findings. Radiology. 172:1989;131-137
10. Weijers R.E., Zambon J.V., Kessels A.G., et al. On the prediction of the histologic component of benign prostatic hyperplasia based on clinical and MRI parameters. Prostate. 32:1997;179-187
11. Ishida J., Sugimura K., Okizuka H., et al. Benign prostatic hyperplasia value of MR imaging for determining histologic type. Radiology. 190:1994;329-331
12. Mimata H., Nomura Y., Kasagi Y., et al. Prediction of alpha-blocker response in men with benign prostatic hyperplasia by magnetic resonance imaging. Urology. 54:1999;829-833
13. Kurita Y., Masuda H., Suzuki K., et al. Transition zone ratio and prostate-specific antigen density as predictors of the response of benign prostatic hypertrophy to alpha blocker and anti-androgen therapy. Br J Urol. 80:1997;78-83
14. Wendel E., Brannen G.E., Putong P.B., et al. The effect of orchiectomy and estrogens of benign prostatic hyperplasia. J Urol. 108:1972;116-119
15. Lee C. Role of androgen in prostate growth and regression stromal-epithelial interaction. Prostate Suppl. 6:1996;52-56
16. Tenniswood M. Role of epithelial-stromal interactions in the control of gene expression in the prostate an hypothesis. Prostate. 9:1986;375-385
17. Jain R.K., Safabakhsh N., Sckell A., et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor role of vascular endothelial growth factor. Proc Natl Acad Sci USA. 95:1998;10820-10825
18. Franck-Lissbrant I., Haggstrom S., Damber J.E., et al. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology. 139:1998;451-456
19. Okihara K., Watanabe H., Kojima M. Kinetic study of tumor blood flow in prostatic cancer using power Doppler imaging. Ultrasound Med Biol. 25:1999;89-94
20. Eckersley R.J., Sedelaar J.P., Blomley M.J., et al. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate. 51:2002;256-267
21. Zelefsky M.J., Liebel S.A., Burman C.M., et al. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 29:1994;755-761
22. Kucway R., Vicini F., Huang R., et al. Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol. 167:2002;2443-2447